Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Atavistik Bio, Inc
Eli Lilly and Company
Intuitive Surgical
Stemline Therapeutics, Inc.
AstraZeneca
Maastricht University Medical Center
Incepta Pharmaceuticals Ltd
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Alliance for Clinical Trials in Oncology
Universitätsmedizin Mannheim
Silesian Centre for Heart Diseases
University Health Network, Toronto
Hoffmann-La Roche
Odense University Hospital
RemeGen Co., Ltd.
Stanford University
University of Chicago
Novartis
TaiHao Medical Inc.
Maastricht University Medical Center
Albert Einstein Healthcare Network
IRCCS San Raffaele
Medipol University
Centro di Riferimento Oncologico - Aviano
Insel Gruppe AG, University Hospital Bern
TaiHao Medical Inc.
BioNumerik Pharmaceuticals, Inc.
Syndax Pharmaceuticals
Sun Yat-sen University
NSABP Foundation Inc
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Syndax Pharmaceuticals
Syndax Pharmaceuticals
University of Illinois at Chicago
KK Women's and Children's Hospital
Uppsala University
Medipol University
Novartis
ChineseAMS
Envision Healthcare Scientific Intelligence, Inc.
Mayo Clinic
Zhejiang Cancer Hospital
Novartis
Peking Union Medical College Hospital
Zhejiang Cancer Hospital
King's College London
Mater Misericordiae University Hospital